Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells.

× No keyword cloud information.

30 in total

1. Gammaretroviral vector integration occurs overwhelmingly within and near DNase hypersensitive sites.

Authors: Mingdong Liu; Chang Long Li; George Stamatoyannopoulos; Michael O Dorschner; Richard Humbert; John A Stamatoyannopoulos; David W Emery
Journal: Hum Gene Ther Date: 2011-12-14 Impact factor: 5.695

2. Gene therapy to the kidney using viral vectors.

Authors: Talha Akbulut; Frank Park
Journal: Paidiatrike Date: 2008

3. High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy.

Authors: Mengxin Li; Giridhara R Jayandharan; Baozheng Li; Chen Ling; Wenqin Ma; Arun Srivastava; Li Zhong
Journal: Hum Gene Ther Date: 2010-10-06 Impact factor: 5.695

Review 4. Recent developments in gene transfer: risk and ethics.

Authors: Jonathan Kimmelman
Journal: BMJ Date: 2005-01-08

5. Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells.

Authors: Dustin J Maxwell; Jesper Bonde; David A Hess; Sarah A Hohm; Ryan Lahey; Ping Zhou; Michael H Creer; David Piwnica-Worms; Jan A Nolta
Journal: Stem Cells Date: 2007-11-29 Impact factor: 6.277

6. Genomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulator.

Authors: Chang Long Li; Ding Xiong; George Stamatoyannopoulos; David W Emery
Journal: Mol Ther Date: 2009-02-24 Impact factor: 11.454

American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells.

1. Gammaretroviral vector integration occurs overwhelmingly within and near DNase hypersensitive sites.

2. Gene therapy to the kidney using viral vectors.

3. High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy.

Review 4. Recent developments in gene transfer: risk and ethics.

5. Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells.

6. Genomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulator.

7. Gene therapy, early promises, subsequent problems, and recent breakthroughs.

Review 8. Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

9. Reducing the genotoxic potential of retroviral vectors.

Review 10. The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors.